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ABSTRACT: The kinetics and mechanism of cleavage of DNA by the insulin-mimetic peroxo-vanadate
NH4[VO(O2)2(phen)], pV, are described. In the presence of low energy UV radiation or biologically
common reducing agents, pV decomposes into the monomer, dimer, and tetramer of vanadate and an
uncharacterized compound of V4+ as shown by 51V NMR, ESR, and absorption spectra. The rate of
photodecomposition of pV is reduced in the presence of calf thymus DNA, indicating that a decomposition
product of the peroxo-vanadate, that is important in the destruction pathway of the complex, is interacting
with DNA. This species, probably a short-lived complex of V4+, may also be responsible for the observed
catalytic decomposition of pV in the absence of DNA by ascorbate. If closed circular pBR322 DNA is
present when the peroxo-vanadate is destroyed by either UV radiation or reducing agents, the polymer
may have its sugar-phosphate backbone broken. Closed circular DNA (form I) is converted into nicked
circular DNA (form II) and linear DNA (form III). The amounts of the various forms produced as a
function of irradiation time and peroxo-vanadate concentration were fit to a kinetic model to derive rate
constants for the conversions. The kinetic analysis shows that pV is a single-strand nicking agent which
exhibits some base and/or sequence preference. Furthermore, the pH dependences of the rates for
conversion of form I to form II and for conversion of form II to form III are different, indicating that the
nature of the chemistry at the site of cleavage on DNA influences further cutting by activated pV. Reduced
amounts of DNA breakage in the presence of various salts and metal binding ligands indicate that a
short-lived reactive complex of V4+, not the V4+ species detected by ESR at long irradiation times, is
important in the cleavage process. The susceptibility of pV to decomposition by biologically common
reducing agents suggests that metabolites of the agent, and not the compound itself, are responsible for
its insulin-mimetic effects.

The peptide hormone insulin is widely used to treat
diabetes. While the compound is successful in regulating
glucose levels in the body, the fact that it must be given by
injection stimulated interest in finding alternatives to insulin
which can be taken orally. In 1979 it was reported that
solutions of vanadate can affect glucose metabolism (Tolman
et al., 1979). Since vanadate salts can be administered orally,
this report prompted investigation of the insulin-mimetic
properties of a large number of vanadium compounds
(Shechter 1990; Shechter et al., 1990; McNeill et al., 1992;
Shaver et al., 1993, 1995; Posner et al., 1994).
It is known that vanadate, V5+, mixed with hydrogen
peroxide can augment the binding of insulin growth factors
to rat adipocytes and activate the insulin receptor kinase
(Kadota et al., 1987; Fantus et al., 1989). Since addition of
hydrogen peroxide to vanadate produces a mixture of
compounds (Jaswal & Tracy, 1991), well characterized
complexes containing V5+ bound to peroxide ligands were
synthesized and their insulin-mimetic properties studied
(Shaver et al., 1993; 1994, 1995; Posner et al., 1994; Fantus
et al., 1994; Bevan et al., 1995). It is known that vanadate
is very likely reduced to vanadyl, V4+, in the body (Sakurai
et al., 1980). This observation stimulated considerable
interest in the insulin-mimetic properties of compounds
containing V4+ bound to malonate, salicylate, hydroxamate,
†
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and other organic ligands (McNeill et al., 1992; Yuen et al.,
1993a,b; Dai et al., 1993; Shechter et al., 1992; Orvig et al.,
1995).
Both diabetes and cancer are characterized by aberrant
metabolic processes, and it is not surprising that vanadium
compounds also exhibit antitumor effects. Complexes of V5+
which contain peroxo and polycarboxylate ligands show
antitumor activity against L1210 leukemia implanted in mice
(Djordjevic & Wampler, 1985; Djordjevic, 1995). Toxicities
of the compounds vary widely from a few mg/kg up to 160
mg/kg. Although the molecular basis for the antitumor
properties is not known, the compounds may undergo
decomposition in ViVo, producing V4+ and superoxide. The
latter could change the free radical character of the cellular
environment, ultimately causing the cell to die (Djordjevic
& Wampler, 1985).
Antitumor effects have also been found for compounds
containing V4+. Dietary vanadyl sulfate is able to block
nitrosourea-induced mammary carcinogenesis in mice
(Thompson et al., 1984), and at very low concentrations in
cell culture (∼10-10 M) the compound inhibits the growth
of human tumor specimens (Hanauska et al., 1987). Biodistribution studies in rats show that V4+ and V5+ accumulate
in the nuclei of liver cells (Sakurai et al., 1992). It has been
proposed that the antitumor effect of V4+ is due to its
oxidation by cellular hydrogen peroxide, which releases
hydroxyl radical. In support of this hypothesis is the
observation that vanadyl sulfate and hydrogen peroxide can
break Col E1 DNA and that hydroxyl radicals are generated
during the cleavage process (Sakurai et al., 1992). The
© 1996 American Chemical Society
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vanadyl complex, [VO(phen)(H2O2)2]2+, shows high antitumor activity toward human nasopharyngeal carcinoma
(Sakurai et al., 1995). The compound may exhibit its
cytotoxic effects by binding to DNA and, in the presence of
hydrogen peroxide, cleave the polymer.
While vanadium salts have potential for treating serious
diseases such as diabetes and cancer, they are also widely
taken by those interested in “body building” and muscle
development. Vanadyl sulfate in tablet form mixed with
vitamins, herbs, and other agents is a dietary supplement
available at most health food stores. The product is thought
to increase glucose uptake by muscle cells, but the biological
fate of the vanadium, and any long term health effects from
extended use of the supplements, are unknown (Domingo
et al., 1995).
In addition to their importance as pharmaceuticals, vanadium compounds have potential for probing the structure of
biological molecules such as proteins and DNA. The simple
vanadate oligomers can photocleave myosin, dynein, and
tubulin in a site-specific manner (Gibbons & Mocz, 1991;
Cremo et al., 1991; Correia et al., 1994). Although the
mechanism of cleavage is not completely characterized,
photolysis in the presence of vanadate oxidizes specific serine
residues of the protein to serine aldehyde. This ultimately
causes a break in the peptide backbone of the protein at the
site of modification. DNA is also a target for cleavage by
vanadium compounds. The antitumor agents, [VO(phen)(H2O)2]+2 and vanadyl bleomycin, can break the sugarphosphate backbone of DNA in the presence of hydrogen
peroxide (Sakurai et al., 1995; Kuwahara et al., 1985). In
the case of vanadyl bleomycin, cleavage most often occurs
at GA sequences of DNA.
The pharmacological and biochemical importance of
vanadium compounds, and the fact that there are many
potential receptor sites for vanadium salts in the body
(Chasteen, 1995), prompted us to investigate the reactivity
of NH4[VO(O2)2(phen)], where phen is 1,10-phenanthroline,
pV, with DNA. The peroxo-vanadate is similar in structure
to compounds earlier tested against L1210 leukemia (Djordjevic & Wampler, 1985), and it is also a member of a class
of V5+ peroxocompounds which exhibit insulin-mimetic
effects (Posner et al., 1994; Bevan et al., 1995). In a
preliminary report we used 51V NMR and absorption to show
that low energy UV light and NADPH decompose pV into
vanadate and that DNA present during the decomposition
will have its sugar-phosphate backbone broken (Hiort et al.,
1995). In this report we study the kinetics and mechanism
of the reaction by which pV cleaves pBR322 DNA in the
presence of UV light, inhibitors, and chemical reducing
agents.
MATERIALS AND METHODS
Materials. Ammonium vanadium oxide (99.995%) was
purchased from Johnson Matthey Materials Technology,
U.K., and 1,10-phenanthroline was obtained from Aldrich
Chemical Co. NH4[VO(O2)2(phen)], pV, was synthesized
according to Vuletic and Djordjevic (1973) which is similar
to the procedure of Posner et al. (1994). The elemental
analysis was performed by Oneida Research Services Inc.
Anal. Calcd for NH4[VO(O2)2(phen)]‚2H2O: C, 39.9; H,
4.4; N, 11.5. Found: C, 39.22; H, 4.38; N, 11.22. The
purity of the compound in D2O was checked using 51V NMR.
Solutions of pV were freshly prepared for the various
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experiments and used within 24 h of preparation. The solid
was stored for extended periods of time (months) in the dark
at room temperature. Concentrations were determined
optically at 270 nm using a molar absorptivity of 25 800
M-1 cm-1. All absorption spectra were obtained with a
Varian Cary 1 spectrophotometer in quartz cells with a 1-cm
path length.
pBR322 plasmid DNA was purchased from Boehringer
Mannheim Biochemical, USA, and ethanol precipitated prior
to use to remove EDTA and Tris present in the storage buffer.
Calf thymus DNA, obtained from Sigma Chemical Co. (St.
Louis), was used without purification. The concentration
of calf thymus DNA, in DNA phosphates, was determined
optically at 258 nm using a molar absorptivity of 6 600 M-1
cm-1. The stated DNA concentrations are the final concentrations in mixtures. Unless otherwise noted, all studies were
carried out in phosphate buffer (0.1 M sodium phosphate,
mono- and diionic forms, pH 6.0), hereafter referred to as
buffer. Cleavage as a function of pH was studied in 0.1 M
phosphate buffer using a number of pH values stated below.
The tert-butyl alcohol, salts, and chemical activators used
in the DNA cleavage studies were reagent grade. Buffers
were from Sigma Chemical Co. (St. Louis).
Spectroscopy. One-dimensional 51V NMR spectra were
recorded at 65.81 MHz on a Bruker 250 MHz NMR
spectrometer using a 10-mm tunable probe either in phosphate buffer containing 50% D2O or in neat D2O. Samples
were run at ambient temperature with a deuterium lock.
Parameters were as follows: pulse angle 90°, sweep width
100 000 Hz, acquisition time 0.005 s, with no relaxation
between pulses. The chemical shifts are reported relative
to the external standard VOCl3 (0 ppm). No exponential
multiplier was used; an 8K data set was collected and zerofilled to 16K. The data were processed on a Sunstation using
the NMR 1 software developed by New Methods Research,
E. Syracuse, NY.
The ESR spectrum of the V4+ species was obtained using
a Varian E-9 spectrometer operating at X-band frequency.
The instrument settings were as follows: magnetic field,
3220 G; microwave frequency, 9.515 GHz; microwave
power, 10 mW; modulation amplitude, 20; scan range, 2000
G; time constant, 0.3 s; scan times, 2 min. Spectra were
run at ambient temperature in water. The magnetic field
was calibrated using a value of the g tensor for DPPH of
2.0036 (McMillan, 1968).
Photolysis. Samples, contained in Exax brand flint glass
test tubes (5-mm path length), NMR tubes (1-cm path
length), or quartz cuvettes (1-cm path length), were irradiated
at a distance of 30 cm using a Blak Ray 100 W long-wave
(λmax ) 365 nm) UV mercury lamp. The relative amounts
of UV intensity incident at various points on the area
illuminated by the lamp were determined by placing glass
test tubes containing identical amounts of pBR322 DNA and
pV in buffer at various points on the area of illumination.
Analysis of the amounts of cleaved DNA in the tubes using
the procedure described below revealed the area of constant
illumination intensity. All irradiation experiments were
carried out with samples located in this area.
Decomposition of pV. A D2O solution (4 mL) containing
25 mM pV in the absence or presence of calf thymus DNA
(8.3 mM base pairs) in a 10-mm NMR tube was irradiated
using low energy UV radiation. The composition of the
solutions as a function of irradiation time was determined
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using 51V NMR and absorption spectroscopy. The decomposition of pV using chemical reducing agents in the absence
of DNA was also studied. A solution containing 0.7 mM
sodium ascorbate and 25 mM pV in 4 mL of D2O was
prepared and the composition of the solution as a function
of time studied with 51V NMR.
CleaVage of pBR322 DNA by pV Using UV Radiation.
The cleavage reactions were carried out in a total volume of
25 µL containing 25 µM pBR322 DNA in buffer. Irradiations were for 30 min using various concentrations of pV:
1, 2, 3, 5, 6, 8, 10, 12, 15, 17, 20, 24, and 32 µM. In a
second series, 25 µM DNA in the presence of 10 µM pV
was irradiated for various times: 2, 4, 6, 8, 10, 12, 14, 16,
18, 22, 25, and 30 min. The DNA forms present in the
reaction mixtures were separated using electrophoresis in a
1% agarose gel. After staining with an ethidium bromide
solution (0.5 µg/mL) for 45 min, the gel, without destaining,
was placed on a UV transilluminator and photographed with
a Polaroid camera using type 55 film. The exposure time
was such that the maximum intensity of all bands was in
the linear response range of the film (Ribeiro et al., 1989;
Prunell et al., 1977). Linearity of measured intensity with
DNA concentration was checked by loading different
amounts of DNA in the gel and, after electrophoresis,
staining, and photography, constructing plots of band intensity versus DNA concentration. The photographic negative
was scanned with a Molecular Dynamics (Model 300A)
microdensitometer to obtain volume integrations of bands.
With these staining conditions, closed circular DNA (form
I) stains with the same efficiency as the other two forms of
pBR322 DNA (Shubsda et al., unpublished results). Since
linear DNA (form III) was not degraded to smaller fragments
in any of the experiments, errors due to loading, nonuniform
illumination of the gel, and optical effects due to the camera
were corrected by normalizing the total intensity of the three
DNA forms in a given lane on the gel to a constant value.
This correction was less than 15% of the total intensity in a
given lane.
In order to show that the reactive species responsible for
cutting was short-lived, irradiations of pV in the absence of
DNA at various times were carried out. Addition of DNA
to the irradiated sample immediately after its removal from
the irradiation device did not result in DNA strand scission
(data not shown).
The efficiency of photocleavage at various values of pH
(4.5, 5.0, 5.5, 6.0, 6.5, and 7.0) in 0.1 M phosphate buffer
was studied by irradiating solutions containing 25 µM
pBR322 DNA and 0, 5, 10, and 15 µM pV, at each value of
pH, for 30 min. Cleavage experiments in buffer (pH 6.0)
were also performed using 20 µM pV and 25 µM pBR322
DNA in the presence of trapping agents and salts. The salts,
NaCl (0-1500 mM) or NaI (0-1500 mM), and the trapping
agents, tert-butyl alcohol (0-4 mM) and thiourea (0-4 mM),
were added prior to pV and the resulting solutions irradiated
for 30 min.
CleaVage of pBR322 DNA with pV Using Chemical
ActiVators. Cleavage of pBR322 DNA (25 µM) with pV
(10 µM) in buffer was carried out in the dark using the
chemical activators NADPH (0-10 mM), glutathione (010 mM), and L-cysteine (0-10 mM). After 30 min, the
reactions were quenched by ethanol precipation, the sample
was redissolved in distilled water, and the product distribution
was determined using quantitative agarose gel electrophore-

Hiort et al.

FIGURE 1: Analysis by 51V NMR of the photodecomposition of
25 mM pV in D2O. The peak at -744 ppm corresponds to pV
while the signals at -558, -571, and -576 ppm are due to the
monomer, dimer, and tetramer of vanadate, respectively. The
samples were irradiated for 0, 45, 85, 120, 180, 225, 270, 335,
480, and 600 min.

sis. While sodium ascorbate could also activate pV to cleave
DNA, the ability of ascorbate to cleave DNA in the absence
of pV complicated quantitative studies with this reducing
agent.
RESULTS AND ANALYSIS
The first experiments described had the goal of characterizing the decomposition of pV induced by UV radiation or
various biochemical agents. In particular, information was
sought about intermediate and final products of decomposition.
Photolysis. Figure 1 shows the 51V NMR spectrum of
pV in D2O before (bottom panel) and after different times
of irradiation (tirr). The complex exhibits a single narrow
(∆δ ) 4 ppm) peak located at -744 ppm arising from the
diamagnetic V5+ ion. When the pV solution is irradiated
with UV light, the metal complex is slowly converted into
three new diamagnetic V5+ species at -576, -571, and -558
ppm, which have earlier been assigned to the tetramer (cyclic
V4O122-, V4), dimer (H2V2O72-, V2) and monomer (H2VO4-,
V1) of vanadate, respectively (Crans, 1994). The ratio
between the products changes, as expected, in favor of the
tetramer as the irradiation time is increased. As decomposition occurs, the yellow color of the solution fades, gas
evolution is observed, and the solution becomes slightly
alkaline, pH ) 8.4. The fact that these are the only vanadium
species observed, even at tirr ) 25 h (results not shown) when
the signal for pV has completely disappeared, shows that
the only diamagnetic end products in the photoreaction are
simple vanadates. At very long irradiation times (tirr >25
h) the 51V NMR base line becomes very distorted, indicating
the presence of a paramagnetic V4+ species in solution. The
solution also changes color from yellow to light brown, and
a fine dark precipitate forms (possibly VO(OH)x).
When calf thymus DNA is present in a D2O solution
containing pV ([pV]/[DNA] ) 3), the photoconversion of
pV into the simple vanadates is slowed significantly (see
Figure 2). This indicates that at least one of the species
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FIGURE 2: Relative concentration of pV (25 mM) as a function of
irradiation time in the absence (spectrum shown in Figure 1) and
presence of calf thymus DNA, [pV]/[DNA] ) 3. Relative concentration was determined using 51V NMR from the area of the signal
at -744 ppm for pV.
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FIGURE 4: Fractional intensities of pV, V1, V2, and V4 as a function
of time after the addition of 0.7 mM sodium ascorbate to 25 mM
pV in water. Fractional intensities were determined using 51V NMR
from the area of a signal divided by the sum of the areas of all
signals.

FIGURE 5: ESR spectrum of a V4+ complex produced by photodecomposition of 25 mM pV in water.

FIGURE 3: Absorption spectra of photolyzed pV in H2O. (A) 0.35
mM pV alone. Individual spectra correspond to irradiation times
(tirr) of 0, 105, 170, 215, and 600 min in order of increasing
absorbance at 450 nm, respectively. (B) 0.35 mM pV plus 0.7 mM
calf thymus DNA. tirr ) 0, 105, 170, 215, and 600 min in order of
increasing absorbance at 320 nm, respectively.

involved in the decomposition of pV is interacting with DNA.
At a time for which ∼25% of pV had decomposed in D2O
without DNA, no vanadate had formed in the presence of
DNA. After 480 min, when no pV could be detected in the
absence of DNA, ∼60% of the V5+ in the solutions
containing DNA remained as pV (Figure 2). No new 51V
NMR active species are formed in the pV/DNA solutions,
either before irradiation or as a result of irradiation, as judged
by the number of peaks and their chemical shifts. This shows
that neither pV nor the simple vanadates interact with DNA,
which is expected since these are all negatively charged
species.
Irradiation of an aqueous solution of pV causes the shape
and intensity of the peroxo LMCT bands in the region 310345 nm (λ ∼900 cm-1 M-1) to change considerably, as
shown in Figure 3A, indicating that the vanadium complex
undergoes a major chemical change as the result of photoir-

radiation. During the first hour, an isosbestic point is
observed at ∼330 nm. With increasing irradiation time,
isosbestic behavior is lost, the absorption increasing monotonically over the region 340-600 nm. After 10 h of
irradiation, the absorption is nearly twice as intense as the
original spectrum. We attribute the new absorption to a V4+
complex formed by the photodecomposition of pV.
Decomposition by Ascorbate. Addition of 0.7 mM sodium
ascorbate to 25 mM pV in D2O also causes decomposition
of the peroxo-vanadate into the simple vanadates. The
decomposition was found to be catalytic with regard to
ascorbate; one ascorbate is able to convert about 10 pV
complexes into the vanadates. A plot of the area of the 51V
NMR signal from the V5+ complexes versus time shows that
the reaction is complete after 30 min at room temperature,
(Figure 4). Moreover, the rate of disappearance of pV is
the same as the rates of appearance of V1, V2, and V4, and
at the end of the observation time the NMR base line is
nonlinear, indicating the presence of V4+ (spectra not shown).
The fact that a V4+ complex is produced in the photodecomposition of pV was established using ESR. When pV
(25 mM in H2O) is irradiated extensively (>12 h), an ESR
spectrum having the characteristic eight line pattern for the
electron on V4+ interacting with the nuclear spin of 51V (I
) 7/2) appears (Figure 5). The values obtained for the
g-tensor and hyperfine coupling constant for the V4+ complex
were 1.967 and 98.7 G, respectively. A V4+ species with
similar ESR parameters has been observed in the V5+
catalyzed decomposition of H2O2 in water (Bonchio et al.,
1994).
To learn more about the interaction of the pV photolysis
products with DNA, pV was irradiated in the presence of
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FIGURE 6: Photograph of an agarose gel stained with ethidium
bromide showing cleavage of pBR322 DNA by pV as a function
of irradiation time in 0.1 M phosphate buffer, pH 6. The forms of
pBR322 DNA are shown at the sides of the photograph. Lane 1,
25 µM DNA alone; lane 2, 25 µM DNA alone, UV radiation (30
min); lanes 3-14, 25 µM DNA, 10 µΜ pV, UV radiation,
irradiation times, increasing right to left, are given in the Materials
and Methods section.
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FIGURE 8: Kinetic analysis of photocleavage of 25 µM pBR322
DNA by 10 µM pV as a function of irradiation time (gel shown in
Figure 6). The experimental points are fit to curves calculated using
the kinetic model.

Eventually, linear DNA may be cut by V* producing smaller
DNA fragments, with rate constant k3, but there is no
evidence for this occurring in the present case. If V* is
destroyed only by its interaction with DNA, its concentration
varies with time according to the following equation:
d[V*]
) -(k1[I][V*] + k′2[II][V*] + k4[I][V*]) ≡ -R[V*]
dt
(1)

FIGURE 7: Kinetic analysis of photocleavage of 25 µM pBR322
DNA as a function of the concentration of pV in 0.1 M phosphate
buffer, pH 6. The experimental points are fit to curves calculated
using the kinetic model.

pBR322 DNA which exists in three forms. As shown in
Figure 6, photoirradiation of samples containing pBR322
plasmid DNA and pV at various times results in the
conversion of the closed circular form (form I) to the nicked
circular (form II) and the linear (form III) forms. From the
relative amounts of the forms, information about cleavage
rate constants may be derived.
Analysis of DNA CleaVage Kinetics. The amounts of DNA
formed as a function of pV concentration and time were
found by measuring the fluorescence intensity of DNA in
agarose gels stained with ethidium bromide. The observed
intensities and fits to the data using the kinetic model are
shown in Figures 7 and 8.
In deriving the kinetic model, we assume that chemical
or photochemical activation of pV produces a species V*
which is responsible for the cutting. We consider that V*
may interact with the DNA by three second-order reactions:
(a) it may nick form I (supercoiled) DNA, converting it into
form II (nicked circular) DNA, with rate constant k1 (singlestrand cutting); (b) it may convert form II DNA, which has
at least one break in one strand, into form III (linear) DNA
by cutting the other strand sufficiently close to the preexisting
nick, with rate constant k2; (c) it may convert form I DNA
directly to form III DNA with rate constant k4 (double-strand
cutting). The conversion of form II DNA to form III actually
involves many second-order reactions because the conversion
rate depends on how many nicks are present in form II DNA;
k2 should be taken as an average or effective rate constant.

The quantity k′2, which is the rate constant for single-strand
nicking of form II DNA by V*, should be much larger than
k2 because few of these nicking events occur close enough
to a preexisting nick to cause conversion of form II to form
III; one may expect k′2 to be closer in size to k1 than to k2.
Other processes which destroy V* would add a term, -k0[V*], to the above expression for d[V*]/dt. Equation 1
shows that [V*] decreases monotonically.
If the rate constants are about the same size, R ) k1[I] +
k′2[II] + k4[I] will be approximately constant. Also, R is
approximately constant for early times, when the concentrations of the three forms of DNA have not changed much;
then, [V*] ) [V*]0(1 - ct), with [V*]0 the initial concentration of V* and c a constant. In addition, [V*] will remain
essentially constant (and R will be ∼0) if [V*]0 is much
larger than the concentration of DNA cutting sites, and there
are no mechanisms for destruction of V* other than DNA
cleavage. In all of these cases, [V*]/[V*]0 varies with time
in a manner independent of [V*]0, i.e.

d ln [V*]
) -f(t)
dt
Integrating,

[V*] ) [V*]0e-F(t)

(2)

where

F(t) ) ∫0 f(t′) dt′
t

Now the concentration of form I DNA obeys

d[I]
) -(k1 + k4)[V*]0e-F(t)[I]
dt
which, on dividing both sides by [I], can be integrated to
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give

ln([I]/[I]0) ) -[V*]0(k1 + k4) G(t)

(3)

where

G(t) ) ∫0 e-F(t′) dt′
t

If the expression for [I] is substituted into the equation for
d[II]/dt, one finds

[II] ) [II]0e-[V*]0k2G(t) -

k1[I]0
[e-[V*]0(k1+k4)G(t) k1 + k 4 - k 2
e-[V*]0k2G(t)] (4)

The differential equation for d[III]/dt may be treated
similarly. One sees that the operative parameters are rate
constants times G(t), rather than the rate constants themselves.
Measurement of Rate Constants. In the present experiments, [V*]0 is not known, only the initial concentration of
pV. The active species V* is generated from pV, and
probably destroyed by interaction with oxygen and other
species in solution as well as with DNA. It seems reasonable
to consider V* as an unstable intermediate, so that d[V*]/dt
is small compared to the rate of creation or the rate of
destruction of V*. Since the rate of destruction is proportional to [V*] and the rate of creation is proportional to [pV],
[V*] is proportional to [pV], say [V*] ) k[pV]. Of course,
[pV] itself decreases with time during digest. In the
expressions for [I], [II], and [III] above, [pV]0 may be
substituted for [V*]0, with the understanding that G(t) is
actually k times the true G(t), where k is less than unity. If
R is assumed to be small, kG(t) is replaced by kt in the
expressions.
This means that one cannot obtain the rate constants
without additional assumptions. The quantities determined,
which we refer to as k1 and k2, are actually k times the actual
rate constants. However, ratios of rate constants, which are
often of interest, can be obtained from experiments in which
initial concentration of cleavage agent is varied with digest
time t kept fixed, or from experiments in which t is varied
with the concentration of cleavage agent held fixed.
A set of experiments of each type has been performed,
with results given in Figures 7 and 8. The smooth curves
in the figures correspond to intensities calculated according
to the theoretical model given above. Values for the initial
amounts of the various DNA forms ([I]0, [II]0, [III]0) and
three rate constant parameters were found to minimize the
sum of the squares of the deviations between calculated and
experimental intensities. In the variable-concentration experiments, the rate constant parameters are k1G(t), k2G(t),
and k4G(t). In the variable-time experiments, we assumed
G(t) equal to t, so the rate constant parameters were k1[V*]0,
k2[V*]0, and k4[V*]0, with [V*]0 ) 10 µM. It was found
that the fit to the experimental intensities was not much
worsened by assuming k4 ) 0 in both experiments, which
shows that there is no appreciable double-strand cutting. With
k4 ) 0 (so there are five parameters: [I]0, [II]0, [III]0, and
two rate constants), the sum of the squares of the deviations
was 0.072 for the variable-time experiments. For the

FIGURE 9: pH dependence, in 0.1 M phosphate buffer, of the rate
constants for photocleavage of closed circular (form I) into nicked
circular (form II), k1, and form II into linear (form III), k2, pBR322
DNA by pV.

variable-concentration experiments, the sum was much less,
only 0.047, which suggests that the assumption G(t) ∼ t is
not completely valid.
The results for the rate constants from the variable-time
experiments were k1 ) 13.8 ( 3.2 (nM)-1 min-1 and k2 )
0.42 ( 0.10 (nM)-1 min-1, assuming G(t) ∼ t. From the
variable-concentration experiments, we obtain k1G(t) ) 720
( 123 (nM)-1 and k2G(t) ) 24.7 ( 8.9 (nM)-1; assuming
G(t) ∼ t ) 30 min makes k1 and k2 24.0 ( 4.1 and 0.82 (
0.29 (nM)-1 min-1, respectively, in fair agreement with the
variable-time results. The ratio k1/k2 ) 29.1 ( 10.5, from
the variable-concentration results, agrees well with the ratio
from the variable-time results; 33.3 ( 7.6. All errors are
standard deviations from the nonlinear least-squares fitting
procedure.
pH Dependence of CleaVage Rates. Fractions of forms I,
II, and III were measured for four different pV concentrations
[pV], at each of five values of pH. The value of k1G
(proportional to the rate constant k1) was extracted by leastsquares fitting the fraction of form I, fI, to an exponential,
Ae-b[pV], for each pH; since there is little double-strand cutting
(direct conversion of form I to form III DNA), b ) k1G.
The uncertainty was estimated by changing one of the
measured values of fI by the estimated error and observing
the change in the calculated value of b. To obtain values of
k2G, we note that, for small values of fIII,

fIII ) fII0(k2G)[D]
where fII° is the initial value of fII, the fraction of form II,
[D] is the total DNA concentration, and G is as earlier
defined. Thus, we fitted the values of fIII to a straight line
and divided the slope by the initial fraction of form II. The
uncertainty was calculated as for k1.
The dependences of k1G and k2G (referred to for brevity
as k1 and k2) on pH are shown in Figure 9. The behaviors
are obviously quite different: k2 decreases linearly with pH
whereas k1 passes through a maximum. These parameters
are referred to as “rate constants”, but the true second-order
rate constants are obtained from the values given for these
parameters by dividing by the DNA concentration, by a
function of the irradiation time (30 min), and by the ratio of
[V*] to [pV].
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Table 1: IC50 Valuesa of Substances Affecting the Cleavage of
pBR322 by pV
IC50 (×mM-1)
Activators
NADPH
0.92
glutathione
0.11
cysteine
0.038

IC50 (×mM-1)
Inhibitorsb
NaCl
550
Nal
8
tert-butyl alcoholc
3.2, 2.9
thioureac
0.65, 0.61

a For activators, this is the concentration of an agent necessary to
decrease the concentration of form I pBR322 DNA to half of its initial
value. For inhibitors, this is the concentration of an agent necessary
to produce a concentration of form I pBR322 DNA half that in the
absence of cleavage. b The method of activation was UV light. c Two
series of experiments.

ActiVators and Inhibitors of DNA CleaVage. The vanadium compound can be activated by NADPH, glutathione,
and cysteine to produce DNA breakage. To determine the
efficiency of a chemical activator of pV, the fraction of form
I DNA was measured after a 30 min digest in the presence
of various concentrations of the activator. This was leastsquares fit to an exponential function of c, the activator
concentration, i.e., fI ) Ae-bc. The value of c required to
reduce fI to half its value before digest, IC50, was calculated
as ln(2)/b. The values of IC50 are given in Table 1.
As the concentration of the reducing agent increases, fI,
the fraction of form I DNA, decreases, except for cysteine.
Although fI can be reduced to zero by 1 mM cysteine, it
increases again for higher cysteine concentrations. The
fraction of form II after digest correspondingly increases for
cysteine concentrations below 1 mM and decreases subsequently as does the fraction of form III DNA. Thus, cysteine
acts as an actiVator at low concentrations, but as an inhibitor
at higher concentrations.
Certain agents, NaI, NaCl, tert-butyl alcohol, and thiourea,
inhibit the ability of pV to photochemically degrade DNA.
We measured the fraction of form I after a 30 min digest as
a function of c, the concentration of the agent. This fraction
increases from zero (complete cleavage) for low values of
c, eventually leveling off at a maximum for a high concentration of agent (minimal cleavage or complete inhibition).
To characterize the inhibitors quantitatively, we fit fI as a
function of c to the equation

f(c) )

Aebc
C + ebc

by choosing the parameters A, C, and b to minimize the sum
of the squares of the deviations between measured and
calculated fI. We then calculate the concentration giving 50%
inhibition, IC50, as b-1 ln(C). The resulting IC50 values for
the inhibitors are given in Table 1.
DISCUSSION
The CleaVage Mechanism. UV light and chemical reducing agents decompose pV into the monomer, dimer, and
tetramer of vanadate (Figures 1, 3, and 4). After extensive
degradation, an uncharacterized complex of V4+ can be
detected using ESR (Figure 5). The initial complex produced
in the photoreduction of pV is a V4+ compound with one of
the peroxide ligands of pV oxidized to superoxide, O2•(Djordjevic et al., 1988; Shinohara & Nakamura, 1989).
Although the fate of this species is unknown, it could lose

superoxide and/or peroxide, ultimately forming an aquated
V4+ compound. This complex would be more substitution
labile than pV and it probably catalyzes the decomposition
of pV into vanadate using an electron transfer/ligand
exchange process similar to that which occurs for complexes
of Pt4+ in the presence of catalytic amounts of Pt2+ (Bailey
& Johnson, 1969; Ellison et al., 1961). That this catalytic
mechanism may be operating is suggested by the decomposition of pV in the presence of ascorbate (Figure 4). The
amount of pV which decomposes to the vanadates is ∼10
times the amount of ascorbate. Since reduction of pV to
V4+ by ascorbate is expected to be stoichiometric, the initial
V4+ compound produced in the reduction or a related species
must catalyze the decomposition of pV into vanadate. The
fact that not all of the pV is converted into vanadate indicates
that pathways also exist for inactivation of the catalytic
species, one of which is interacting with DNA. This is
evident from the lower rate of photodecomposition of pV in
the presence of DNA (Figure 2). The simplest explanation
for the reduced rate is that DNA serves as a quenching agent
for the species, a complex of V4+, which is involved in the
decomposition pathway of pV. It is likely that the same
species causes breakage of DNA. Although ESR shows the
presence of a V4+ complex at extended irradiation times in
the absence of DNA (Figure 5), this complex is probably
not responsible for breakage. Irradiation of pV for various
times followed by addition of DNA does not result in DNA
breakage, indicating that the species responsible for cutting
is short-lived (Material and Methods).
Since both UV light and chemical reducing agents are able
to activate pV, and O2•- is generated only in the photoreaction, superoxide ion is probably not the species responsible
for DNA breakage. This is consistent with earlier studies
by Graham et al. (1980), who showed that free superoxide
ion is relatively unreactive toward DNA.
Hydroxyl radical has been implicated in the cleavage of
DNA by vanadyl compounds in the presence of hydrogen
peroxide. The antitumor agent, [VO(phen)(H2O)2]2+, and
the complex between the anticancer drug bleomycin and
vanadyl sulfate both catalyze the decomposition of hydrogen
peroxide to hydroxyl radical (Sakurai et al., 1992, 1995;
Kuwahara et al., 1985). If DNA is present, hydrogen
peroxide mixtures of the compounds break the sugarphosphate backbone of the polymer. Although the cleavage
mechanism has not been characterized, hydroxyl radical can
be trapped in these reactions, suggesting that it is the species
responsible for breakage. However, vanadyl-bleomycin and
probably also [VO(phen)(H2O2)2] bind to DNA and it may
be that a peroxo-V4+ species bound to the polymer is
responsible for breakage. It is known that the vanadyl/
peroxide system can produce trapped hydroxyl radical not
only by the usual route of interaction of the free radical with
the trap but also through direct interaction of another metal
complex bearing a radical with the trap (Carmichael, 1990;
Butler et al., 1994). The events taking place in the vanadyl/
hydrogen peroxide system probably resemble those occurring
with pV in the presence of UV light or reducing agents.
However, in the case of pV, peroxide is already bound to
the metal ion and it is only necessary to reduce V5+ to V4+
by chemical or photochemical means in order to produce
species which can damage DNA.
The involvement of a metal complex in the breakage
process is supported by the effects of various inhibitors on

Peroxo-Vanadate Cleavage of DNA
the cleavage reaction. As we showed earlier, dissolved
oxygen gas inhibits the photocleavage reaction (Hiort et al.,
1995). Since oxygen could oxidize a V4+ species to V5+,
its presence in solution would reduce the amount of reactive
intermediate available for breakage. Table 1 shows that
thiourea stongly inhibits cleavage in the reactions activated
with UV light. As a good metal binding ligand (Huheey et
al., 1993), thiourea probably prevents the reactive intermediate from binding directly to DNA by blocking metal
coordination sites necessary for binding. Table 1 shows that
I- is strongly inhibitory while Cl- is not. Iodide is a better
metal binding ligand than chloride, especially toward ions
in lower oxidation states, so it may inhibit the reaction like
thiourea, by binding to sites on a V4+ complex, blocking
the interaction of the compound with DNA.
The inhibitory effect of tertiary butyl alcohol, a poor metal
binding ligand, is not consistent with a metal based intermediate as the species responsible for breakage. However,
the alcohol is an effective trap for radicals. A number of
different radicals have been implicated in the decomposition
of peroxovanadates in water (Bronchio et al., 1994), and it
may be that a radical pathway also exists for DNA breakage.
As shown in Table 1, the reducing agents cysteine,
glutathione, and NADPH can be used to activate pV. The
effectiveness of cysteine is probably related to the fact that
it is the smallest of the three reducing agents and can thus
attack the vanadium ion in the sterically crowded peroxovanadate (Shaver et al., 1994). This would be the initial
step in the reduction to produce the reactive V4+ complex.
Although cysteine effectively induces strand scission at low
concentrations, it inhibits cleavage at concentrations above
∼1 mM. Since cysteine is a good metal binding ligand, it
probably inhibits cleavage at high concentration in the same
way that thiourea inhibits breakage in the photoactivation
reaction, i.e., by direct interaction with a reactive V4+
complex. Clearly, additional work on both the nature of the
metal species present in solution and the chemistry taking
place on DNA will be necessary in order to fully characterize
the mechanism by which pV is able to cleave DNA.
Kinetics of DNA CleaVage by pV. The results of the
kinetic studies provided information on the mechanism of
the cleavage reaction. As we have earlier shown (Kishikawa
et al., 1991; Sehlstedt et al., 1994), quantitatively analyzing
the cleavage kinetics of a agent using closed circular DNAs
can give valuable information on the ratios of rate constants
for cutting the various DNA forms and in some instances
the values of the rate constants themselves. Since pV itself
does not bind to and cleave DNA, it is not the species directly
responsible for cleavage. Rather it must be activated to a
species, V* (a complex of V4+), which cleaves DNA using
the mechanism outlined above. Obtaining rate constants for
the cleavage of the various forms of pBR322 DNA would
require knowledge of how the concentration of V* is related
to [pV], which can be measured.
By analyzing the variable-time experiments, we obtained
k1 ) 13.8 (nM)-1 min-1 and k2 ) 0.42 (nM)-1 min-1. From
the variable-concentration experiments, we derive k1 ) 24.0
(nM)-1 min-1 and k2 ) 0.82 (nM)-1 min-1. The fair
agreement between the two sets of values implies that F(t)
(see eqs 1-4) is not large for t <30 min, the duration of the
digests in the variable-concentration experiments. This
means that the concentration of V* does not change much
during the digest time of 30 min.
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The ratio of rate constants, k1/k2, is ∼31. Note that k1 is
the rate constant for single-strand cleavage of form I DNA
and k2 the rate constant for single-strand cleavage of form
II DNA at positions sufficiently near (∼10 base pairs) a
preexisting cut on the opposing strand to transform form II
to linear form III DNA. If cleavage were random, and if
the rate of single-strand cleavage of form II were comparable
to that of form I, the value of k1/k2 for pBR322 DNA, which
has a 4.3 kb genome, should be ∼1000. Since the ratio is
much less than this value, pV probably exhibits some base
and/or sequence specificity, i.e., cleavage is not random on
the genome.
Figure 9 shows that the values of k1 and k2 depend
differently on pH. The rate constant for cleavage of form I
to form II, k1, exhibits a maximum at pH ∼5.5. This suggests
that the amount of the activated species producing breakage
is greatest at this pH and/or the chemistry on DNA leading
to the break is most effective at this pH. Figure 9 also shows
that it becomes more difficult to make form III DNA from
form II as the pH is raised. Since form III can only be
produced by cuts which are sufficiently close to one another
on opposing strands (within ∼10 base pairs), the chemical
change accompanying cleavage on one strand may be
inhibiting the cleavage agent from binding to and cleaving
the opposing strand. A change in pH may change the state
of ionization at the breakage site which would affect the
binding of a charged species nearby, so the pH dependence
of k2 suggests that the agent responsible for breakage may
be a charged species such as a metal complex.
Biological Significance. In this work we show that the
insulin-mimetic compound pV, in the presence of UV light
or biologically common reducing agents, breaks DNA. If
the compound is able to cross the cellular membrane and
enter the nuclear envelope, it could be activated by reducing
agents present in the envelope to cleave DNA in the cell.
Whether or not DNA breakage actually occurs in cells which
have been exposed to pV has not yet been determined.
However, as we show in this report, the complex is readily
degraded by biological reducing agents and light, and perhaps
metabolites of pV, and not the compound itself, are present
in the biological system. Thus, with pV as well as with other
vanadium compounds (Crans et al., 1995; Macara et al.,
1980; Sakurai et al., 1981), modification by agents present
in the biological system may be important in the molecular
mechanism of their insulin-mimetic effects. To unravel the
mechanisms by which pV and related vanadium compounds
are able to exhibit insulin-mimetic or antitumor effects will
require additional knowledge of their stability and reactivity
with important cellular targets such as proteins and DNA.
The potential of pV as a footprinting agent or structural
probe for DNA has not gone unnoticed. Similar to [Cu(phen)2]2+ and related tris-bidentate chelates (Sigman, 1986;
Barton, 1986), the species responsible for cutting has a
phenanthroline ring which may intercalate into DNA (Satyanaryana et al., 1993). In addition, the compound is
relatively stable as a solid and its concentration in solution
can be accurately determined using absorbance. Exposure
of solutions of pV to UV radiation produces a short-lived
intermediate which cleaves DNA. As this study shows, the
amount of cleavage by pV is readily controlled, suggesting
that the compound may be useful in quantitative footprinting
studies. Future work will focus on the cleavage specificity
of the agent and on its ability to accurately measure ligand-
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DNA binding constants in the quantitative footprinting
experiment.
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